Each program strengthens the pharma value chain, impacting the core areas of clinical development, supply chain, and manufacturing and commercial engagement.
Jessica Jarvis and Daniel Blessing
Advertisement
Articles by Jessica Jarvis and Daniel Blessing
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
Study Claims Ozempic Lowers Biological Age
3
GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate
4
Pharmaceutical Executive Daily: New Research Suggests Ozempic May Reduce Biological Age
5
